Text & Context Newsletter: Weekly Roundup

Dear Readers,

Welcome to the latest edition of BananaIP's Text & Context IP Newsletter! This edition presents cases on setting aside of trademark and patent refusal orders, interim Injunction against the mark “XIGAMET”, and execution of injunction against use of the mark “BETNEVIN. A summary of each judgment and extracts of relevant paragraphs are available in the individual posts.

Latest News

Another Dis’connected’ order by the registry, set aside by the Court

Delhi High Court Reverses Patent Office Decision: Honeywell's Amendments Upheld

Diabetic Product XigaMet Loses to ZitaMet Under Heightened Pharma Trademark Scrutiny

Glaxo's BETNESOL vs Zee's BETNEVIN : Who do you BET on?

These cases illustrate that the judiciary continues to play a pivotal role in correcting administrative decisions, as seen in Honeywell's successful appeal against the Patent Office's refusal and the setting aside of an unreasoned trademark refusal. The decisions in favor of ZitaMet and Glaxo’s BETNESOL reflect the evolving standards in pharmaceutical trademark protection. 

For more information or any questions about Intellectual Property, please contact BananaIP at contact@bananaip.com or visit us at www.bananaip.com.